Literature DB >> 25010639

COX inhibitors for the treatment of migraine.

Stephen D Silberstein1, Jessica C Stirpe.   

Abstract

INTRODUCTION: Migraine is a common headache disorder that causes significant disability. COX inhibitors (also referred to as NSAIDs) are a frequently used treatment option. AREAS COVERED: A PubMed search provided articles relating to migraine and COX inhibitors. This article reviews the mechanism of action of NSAIDs in migraine, specifically the inhibition of COX isoenzymes and prostaglandin synthesis. Their central and peripheral effects are reviewed. The evidence for the use of NSAIDs in acute, preventive and rescue therapy, as well as other special circumstances, is discussed. EXPERT OPINION: We use NSAIDs as first-line acute treatment for migraine in both out-patient and in-patient settings, as well as for preventive treatment in menstrual migraine. We also employ NSAIDS as a bridge therapy. We feel more research is needed to develop a greater variation of dosage forms for current NSAIDs as well as more combination therapies.

Entities:  

Keywords:  COX inhibitor; NSAID; migraine

Mesh:

Substances:

Year:  2014        PMID: 25010639     DOI: 10.1517/14656566.2014.937704

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  8 in total

Review 1.  Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.

Authors:  Jonathan Jia Yuan Ong; Milena De Felice
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

2.  P003. NSAIDs for symptomatic treatment of headache.

Authors:  Giannapia Affaitati; Paolo Martelletti; Mariangela Lopopolo; Claudio Tana; Francesca Massimini; Francesco Cipollone; Domenico Lapenna; Maria Adele Giamberardino; Raffaele Costantini
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

3.  Effects of NSAIDs on the Release of Calcitonin Gene-Related Peptide and Prostaglandin E2 from Rat Trigeminal Ganglia.

Authors:  Vittorio Vellani; Giorgia Moschetti; Silvia Franchi; Chiara Giacomoni; Paola Sacerdote; Giada Amodeo
Journal:  Mediators Inflamm       Date:  2017-10-25       Impact factor: 4.711

4.  Electroacupuncture Inhibits Hyperalgesia by Alleviating Inflammatory Factors in a Rat Model of Migraine.

Authors:  Luopeng Zhao; Lu Liu; Xiaobai Xu; Zhengyang Qu; Yupu Zhu; Zhijuan Li; Jingxia Zhao; Linpeng Wang; Xianghong Jing; Bin Li
Journal:  J Pain Res       Date:  2020-01-13       Impact factor: 3.133

Review 5.  Medication overuse and drug addiction: a narrative review from addiction perspective.

Authors:  Tatiane Teru Takahashi; Raffaele Ornello; Giuseppe Quatrosi; Angelo Torrente; Maria Albanese; Simone Vigneri; Martina Guglielmetti; Cristiano Maria De Marco; Camille Dutordoir; Enrico Colangeli; Matteo Fuccaro; Davide Di Lenola; Valerio Spuntarelli; Laura Pilati; Salvatore Di Marco; Annelies Van Dycke; Ramla Abuukar Abdullahi; Antoinette Maassen van den Brink; Paolo Martelletti
Journal:  J Headache Pain       Date:  2021-04-28       Impact factor: 7.277

Review 6.  Recent advances in migraine therapy.

Authors:  Fabio Antonaci; Natascia Ghiotto; Shizheng Wu; Ennio Pucci; Alfredo Costa
Journal:  Springerplus       Date:  2016-05-17

7.  Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.

Authors:  Hashmat Ghanizada; Mohammad Al-Mahdi Al-Karagholi; Nanna Arngrim; Mette Mørch-Rasmussen; Matias Metcalf-Clausen; Henrik Bo Wiberg Larsson; Faisal Mohammad Amin; Messoud Ashina
Journal:  J Headache Pain       Date:  2020-02-24       Impact factor: 7.277

8.  Auricular Electrical Stimulation Alleviates Headache through CGRP/COX-2/TRPV1/TRPA1 Signaling Pathways in a Nitroglycerin-Induced Migraine Rat Model.

Authors:  Chung-Chih Liao; Jung-Miao Li; Ching-Liang Hsieh
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-11       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.